International Business Machines CorpIBM

IBM’s latest quarterly filing reads like a love letter to the long-term investor and a polite memo to the rest of us: $17.16 billion in revenues, $2.17 billion in net income, and $7.77 billion of operating cash flow for the six months to 30 June 2026. Those headline numbers are the kind that make pension funds nod along while sipping decaf in a Canary Wharf meeting room. Yet beneath the glossy press release lies a more prosaic truth: $8.7 billion of the top line was deferred income sitting on the balance sheet at New Year’s Eve, mainly software and services tied to IBM’s mainframe and storage leases. In plain English, IBM is collecting rent on last year’s promises while hoping the z17 rollout keeps the cheques clearing.

What IBM actually sells is a sprawling stack of hardware, software, and services that keep the world’s banks, manufacturers, and governments humming. Its Maximo suite is sold as a crystal-ball in a box-AI-driven maintenance software that is supposed to slash downtime and costs. The filing, however, does not reveal how many actual customers are signing renewal cheques or whether those contracts are growing faster than the support tickets. The storage division flogs FlashSystem all-flash arrays and hybrid beasts under a “zero downtime” guarantee, but the balance sheet still carries $1.75 billion of inventory; the filing’s only clue to velocity is a net $70 million inventory drawdown in the prior annual filing, which tells us the stock is turning, just not how fast.

The cash-generative machine is real: $7.17 billion in the bank and $7.77 billion in operating cash flow give the board plenty of dry powder for buybacks or bolt-ons. The downside is that liabilities sit at $117.56 billion, so the equity cushion is a relatively slender $34.45 billion-enough to keep the lights on, but not enough to fund a decade-long sub-1 nm fabrication ramp without partners. Research and development still clocks in at $2.31 billion for the half year, a sum that is large in absolute terms but small as a share of revenue, suggesting IBM is hedging its bets across mainframes, AI tooling, and hybrid cloud rather than swinging for a single moon-shot. Earnings per share came in at $2.27, supported by 953.3 million diluted shares-so dilution is not the headline risk here, but the sustainability of growth is.

For context, the stock trades on the New York Stock Exchange under the ticker IBM, but the regional filing is the IBM 10-Q filed with the SEC on 23 July 2026. The company’s investor relations page is the canonical source for the latest filings, and the official newsroom’s sub-1 nm chip announcement is the closest thing we have to a product proof-point, even though the filing itself contains no revenue or margin from the technology. The Maximo, Confluent, and FlashSystem product pages describe the pitch, but they do not quantify customer uptake, renewal rates, or margin expansion. If you want the numbers that actually matter-revenue mix, segment margins, free cash flow conversion-the 10-Q is the only place that matters.

The filing also flags a $19 million warranty accrual in the first quarter, a figure that looks modest until you remember that IBM’s customer base spans industries where a single warranty claim can involve a semiconductor fab or a hospital MRI. The absence of a detailed warranty roll-forward table in the 10-Q means we have to take IBM’s word that the liability is properly reserved, which is fine-until it isn’t. The company’s 8-Ks over the past two weeks are routine: routine debt issuance, routine routine board committee updates, routine routine routine. Nothing screams “breakthrough” or “blow-up.” That is either boring competence or the quiet before the storm; the filing data leans toward the former.

What we still do not know: segment-level revenue and operating income, free cash flow, capital expenditure breakdown beyond the aggregate $461 million for PP&E, and any colour on the sub-1 nm chip’s path to revenue. The IBM Confluent and IBM Storage FlashSystem product pages are glossy brochures, not income statements. Until the next 10-Q or an investor day slide deck drops those numbers, the market is trading on faith that the deferred income will convert and the new chips will scale. Faith is a fine product, but it depreciates faster than a mainframe in a server room with no air conditioning.